Next step toward track and trace requirements taken
Executive Summary
FDA's recently issued draft guidance on what should be included as part of a package-level standardized numerical identifier serves "an initial step to facilitating other measures for securing the drug supply chain" based on requirements included in the FDA Amendments Act. The agency is seeking comment on guidance that describes the SNI as being composed of the National Drug Code "that reflects each corresponding manufacturer or repackager, combined with a unique eight-digit numerical serial number generated by the manufacturer or repackager for each individual package." FDA says this identification "can in turn facilitate authentication and tracking and tracing of the prescription drugs." FDAAA requires the implementation of an SNI no later than 30 months after its Sept. 27, 2007 enactment. FDA's guidance does not address technologies that would be used to read the identifier. In March 2008 FDA requested public input on the status of e-pedigree technology and standards development (1"The Pink Sheet," March 31, 2008, p. 20). Comments on the draft guidance are due April 16
You may also be interested in...
FDA Begins Review Of E-Pedigree Options Just As California Delays Its Plan
With testimony that fewer than one in seven pharmaceutical manufacturers could be ready for California's planned implementation of electronic pedigree rules on Jan. 1, 2009, the State Board of Pharmacy decided to delay implementation for another two years
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.